XTL BIOPHARMACEUTICALS-ADR (XTLB)
US98386D3070 - ADR
| 2018 (2018-12-31) | 2017 (2017-12-31) | 2016 (2016-12-31) | 2015 (2015-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | 2.99M | -780.00K | -2.55M | -4.31M | |||
| Depreciation Amortization | N/A | 0.00 | 0.00 | 10.00K | |||
| Change In Working Capital | -10.00K | 50.00K | -220.00K | -20.00K | |||
| Other non cash items | -3.79M | -400.00K | 1.03M | 2.51M | |||
| OPERATING CASH FLOW | -820.00K | -1.13M | -1.73M | -1.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | 0.00 | 0.00 | -70.00K | -70.00K | |||
| Other Investing Activity | 780.00K | -2.50M | 0.00 | -40.00K | |||
| INVESTING CASH FLOW | 780.00K | -2.50M | -70.00K | -110.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Stock Issued/Repurchased | 0.00 | 4.89M | 0.00 | 3.56M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | 20.00K | |||
| FINANCING CASH FLOW | 0.00 | 4.89M | 0.00 | 3.58M | |||
| Exchange Rate Effect | 0.00 | 0.00 | N/A | 0.00 | |||
| CHANGE IN CASH | -40.00K | 1.26M | -1.80M | 1.66M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -820.00K | -1.13M | -1.73M | -1.81M | |||
| Capital Expenditure | 0.00 | 0.00 | -70.00K | -70.00K | |||
| FREE CASH FLOW | -820.00K | -1.13M | -1.80M | -1.88M | |||
All data in USD